搜尋
eXoZymes Inc
EXOZ添加自選
8.480USD
-0.020-0.24%
收盤 07/02, 13:00（美東）報價延遲15分鐘
71.29M總市值
虧損本益比TTM
關於 eXoZymes Inc 公司
eXoZymes Inc, formerly Invizyne Technologies, Inc., is an artificial intelligence (AI) engineered enzyme that can transform sustainable feedstock into essential chemicals, medicines, and biofuels. The Company has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.
eXoZymes Inc簡介
公司代碼EXOZ
公司名稱eXoZymes Inc
上市日期Nov 13, 2024
CEOHeltzen (Michael)
員工數量31
證券類型Ordinary Share
年結日Nov 13
公司地址750 Royal Oaks Dr
城市MONROVIA
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編91016
電話16264151488
網址https://exozymes.com/
公司代碼EXOZ
上市日期Nov 13, 2024
CEOHeltzen (Michael)
eXoZymes Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Paul Hideo Opgenorth, Ph.D.
Dr. Paul Hideo Opgenorth, Ph.D.
Vice President - Development
Vice President - Development
647.49K
+0.62%
Mr. Edgardo Rayo
Mr. Edgardo Rayo
Director
Director
77.91K
--
Mr. Fouad Nawaz
Mr. Fouad Nawaz
Vice President - Finance
Vice President - Finance
9.49K
+63.23%
Mr. Michael Heltzen
Mr. Michael Heltzen
Chief Executive Officer
Chief Executive Officer
--
-100.00%
Dr. Tyler Korman, Ph.D.
Dr. Tyler Korman, Ph.D.
Vice President - Research
Vice President - Research
--
--
Mr. Christopher A. (Chris) Marlett
Mr. Christopher A. (Chris) Marlett
Chairman of the Board
Chairman of the Board
--
--
Mr. Anthony DiGiandomenico
Mr. Anthony DiGiandomenico
Director
Director
--
--
Dr. James U. Bowie, Ph.D.
Dr. James U. Bowie, Ph.D.
Independent Director
Independent Director
--
--
Dr. James J. (Jim) Lalonde, Ph.D.
Dr. James J. (Jim) Lalonde, Ph.D.
Independent Director
Independent Director
--
--
Dr. Lon Edward Bell, Ph.D.
Dr. Lon Edward Bell, Ph.D.
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Paul Hideo Opgenorth, Ph.D.
Dr. Paul Hideo Opgenorth, Ph.D.
Vice President - Development
Vice President - Development
647.49K
+0.62%
Mr. Edgardo Rayo
Mr. Edgardo Rayo
Director
Director
77.91K
--
Mr. Fouad Nawaz
Mr. Fouad Nawaz
Vice President - Finance
Vice President - Finance
9.49K
+63.23%
Mr. Michael Heltzen
Mr. Michael Heltzen
Chief Executive Officer
Chief Executive Officer
--
-100.00%
Dr. Tyler Korman, Ph.D.
Dr. Tyler Korman, Ph.D.
Vice President - Research
Vice President - Research
--
--
Mr. Christopher A. (Chris) Marlett
Mr. Christopher A. (Chris) Marlett
Chairman of the Board
Chairman of the Board
--
--
常見問題
eXoZymes Inc的前五大股東是誰？
eXoZymes Inc的前五大股東如下：Dr. Paul Hideo Opgenorth, Ph.D.
有多少機構持有eXoZymes Inc(EXOZ)的股份？
截至2026Q1，共有13家機構持有eXoZymes Inc的股份，合計持有的股份價值約為94.24K，占公司總股份的1.11% 。與2025Q4相比，機構持股有所增加，增幅為16676.00。